HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward H Giannini Selected Research

rilonacept

7/2014Enhancing crossover trial design for rare diseases: limiting ineffective exposure and increasing study power by enabling patient choice to escape early.
1/2014The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever.
9/2013Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
10/2012Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
8/2012Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward H Giannini Research Topics

Disease

26Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2019 - 01/2003
4Arthritis (Polyarthritis)
01/2014 - 11/2005
4Infections
01/2014 - 01/2003
3Familial Mediterranean Fever (Periodic Disease)
07/2014 - 10/2012
3Dermatomyositis (Dermatopolymyositis)
11/2010 - 03/2003
3Myositis (Idiopathic Inflammatory Myopathies)
04/2010 - 03/2003
2Rheumatic Diseases (Rheumatism)
07/2018 - 01/2018
2Fever (Fevers)
09/2013 - 08/2012
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2010 - 06/2006
1Autoimmune Diseases (Autoimmune Disease)
11/2017
1Inclusion Body Myositis
11/2017
1Lung Diseases (Lung Disease)
11/2017
1Rare Diseases (Rare Disease)
07/2014
1Exanthema (Rash)
09/2013
1Injection Site Reaction
10/2012
1Headache (Headaches)
05/2012
1Fatigue
05/2012
1Arthralgia (Joint Pain)
05/2012
1Myalgia
05/2012
1Chest Pain (Chest Pains)
05/2012
1Neoplasms (Cancer)
03/2011
1Pain (Aches)
11/2010
1Inflammation (Inflammations)
09/2010
1Polymyositis
04/2010
1Hypercalciuria
12/2008
1Necrosis
08/2008
1Tenosynovitis
06/2004
1Anemia
06/2004
1Leukocytosis (Pleocytosis)
06/2004
1Experimental Arthritis
11/2002
1Nephritis
07/2002
1Proteinuria
07/2002

Drug/Important Bio-Agent (IBA)

5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 08/2008
5rilonaceptFDA Link
07/2014 - 08/2012
5Rheumatoid FactorIBA
01/2014 - 06/2004
5Etanercept (Enbrel)FDA Link
03/2011 - 01/2003
5Methotrexate (Mexate)FDA LinkGeneric
11/2010 - 09/2007
4Abatacept (Orencia)FDA Link
10/2015 - 08/2008
3Antirheumatic Agents (DMARD)IBA
10/2015 - 08/2008
3Infliximab (Remicade)FDA Link
09/2010 - 09/2007
2Biological ProductsIBA
07/2018 - 01/2013
2Celecoxib (Celebrex)FDA Link
01/2014 - 01/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2012 - 12/2008
2Antinuclear AntibodiesIBA
05/2012 - 06/2004
2Naproxen (Naprosyn)FDA LinkGeneric
01/2009 - 05/2006
2DNA (Deoxyribonucleic Acid)IBA
11/2002 - 07/2002
1S100A12 ProteinIBA
01/2019
1Pharmaceutical PreparationsIBA
07/2018
1Prostaglandins AIBA
01/2018
1Oncogene Proteins (Oncogene Protein)IBA
01/2018
1AutoantibodiesIBA
01/2018
1AutoantigensIBA
01/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2014
1Proteins (Proteins, Gene)FDA Link
09/2013
1ColchicineFDA LinkGeneric
10/2012
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2010
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
04/2010
1Hormones (Hormone)IBA
12/2008
1CreatinineIBA
12/2008
1CalciumIBA
12/2008
1Biomarkers (Surrogate Marker)IBA
12/2008
1Adalimumab (Humira)FDA Link
08/2008
1rofecoxib (Vioxx)FDA Link
05/2006
1Immunoglobulin G (IgG)IBA
07/2002
1Peptides (Polypeptides)IBA
07/2002

Therapy/Procedure

14Therapeutics
01/2019 - 03/2003
1Polypharmacy
11/2017